Skip to search formSkip to main contentSkip to account menu

Cynt

Known as: Lilly brand of moxonidine 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

moxonidine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
[The efficacy and safety of moxonidine in patients with metabolic syndrome (the O.B.E.Z.I.T.A. trial)].
INTRODUCTION Treatment with agents neutral to lipid metabolism but with a positive effect on glucose metabolism might… 
2010
2010
[Combination therapy of hypertension in general clinical practice. The results of the KOHYBA study].
INTRODUCTION The aim of hypertension treatment is to achieve blood pressure target values; in the majority of patients this is… 
2001
2001
ИЗУЧЕНИЕ МЕТАБОЛИЧЕСКИХ ЭФФЕКТОВ МОКСОНИДИНА У БОЛЬНЫХ С АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ И САХАРНЫМ ДИАБЕТОМ 2 ТИПА
Metabolic effects of moxsonidine (cynt) were examined in 15 patients with mild and moderate arterial hypertension (blood-pressure… 
Highly Cited
1993
Highly Cited
1993
A physiological role for cyanate-induced carbonic anhydrase in Escherichia coli
Cyanate induces expression of the cyn operon in Escherichia coli. The cyn operon includes the gene cynS, encoding cyanase, which… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)